Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Rigel Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.

Get RIGL alerts

About David Santos

The proxy statement of Rigel Pharmaceuticals Inc reports total compensation of $1,382,463 for David Santos in fiscal 2024, including a base salary of $496,080. Disclosed compensation is on record for 6 fiscal years. Rigel Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rigel Pharmaceuticals Inc includes Raul R. Rodriguez (CEO and Board Member), Raul Rodriguez (CEO and Board Member), Dean Schorno (CFO) and 7 others.

Affiliation history

Company network

Leadership on record at Rigel Pharmaceuticals Inc

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Rigel Pharmaceuticals Inc (RIGL) $496,080 $1,382,463
2023 Rigel Pharmaceuticals Inc (RIGL) $477,000 $1,341,791
2022 Rigel Pharmaceuticals Inc (RIGL) $450,000 $1,124,415
2020 Rigel Pharmaceuticals Inc (RIGL) $163,726 $1,190,602
2019 Rigel Pharmaceuticals Inc (RIGL) — —
2018 Rigel Pharmaceuticals Inc (RIGL) — —

Recent activity

No call appearances or filed executive changes recorded yet.